Ahmed A Kolkailah

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 22

Top Topics

Coronary Artery Disease

Cardiovascular Disease

Aortic Valve Replacement

Top Venues

Diabetes, obesity & metabolism

Heart (British Cardiac Society)

Journal of the American Heart Association

Circulation. Cardiovascular quality and outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Ambarish Pandey, Ahmed A Kolkailah, Francesco Cosentino, Christopher P Cannon, Robert C Frederich, David Z I Cherney, Samuel Dagogo-Jack, Richard E Pratley, Nilo B Cater, Ira Gantz, James P Mancuso, Darren K McGuire
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial. European heart journal (2023)
Eric J Hall, Colby R Ayers, Ahmed A Kolkailah, Christine Rutan, Jason Walchok, Joseph H Williams, Tracy Y Wang, Fatima Rodriguez, Steven M Bradley, Laura M Stevens, Jennifer L Hall, Pratheek Mallya, Gregory A Roth, David A Morrow, Mitchell S V Elkind, Sandeep R Das, James A de Lemos
Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. Cardiovascular quality and outcomes (2023)
Ann Marie Navar, Ahmed A Kolkailah, Anand Gupta, Kristin Khalaf Gillard, Marc K Israel, Yiqing Wang, Eric D Peterson
Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients. Circulation. Cardiovascular quality and outcomes (2023)
Ahmed A Kolkailah, Ildiko Lingvay, Idit Dobrecky-Mery, Alona Aharonovich, Jens-Peter David, Cecilie Holse, Søren Rasmussen, Darren K McGuire
Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial. Diabetes, obesity & metabolism 25 (4) (2022)
Ahmed A Kolkailah, Ildiko Lingvay, Idit Dobrecky-Mery, Alona Aharonovich, Jens-Peter David, Cecilie Holse, Søren Rasmussen, Darren K McGuire
Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial. Diabetes, obesity & metabolism (2022)
Ahmed A Kolkailah, Ildiko Lingvay, Idit Dobrecky-Mery, Alona Aharonovich, Jens-Peter David, Cecilie Holse, Søren Rasmussen, Darren K McGuire
Effects of Once-Weekly Subcutaneous Semaglutide on Coronary Artery Disease Outcomes in Patients with Type 2 Diabetes with or at High Risk for Cardiovascular Disease: Insights from the SUSTAIN-6 Trial. Diabetes, obesity & metabolism (2022)
Ahmed A Kolkailah, Ildiko Lingvay, Idit Dobrecky-Mery, Alona Aharonovich, Jens-Peter David, Cecilie Holse, Søren Rasmussen, Darren K McGuire
Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial. Diabetes, obesity & metabolism 25 (4) (2022)
Ahmed A Kolkailah, Ildiko Lingvay, Idit Dobrecky-Mery, Alona Aharonovich, Jens-Peter David, Cecilie Holse, Søren Rasmussen, Darren K McGuire
Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial. Diabetes, obesity & metabolism 25 (4) (2022)
Ahmed A Kolkailah, Kayla Riggs, Ann Marie Navar, Amit Khera
COVID-19 and Cardiometabolic Health: Lessons Gleaned from the Pandemic and Insights for the Next Wave. Current atherosclerosis reports 24 (8) (2022)
Matthew W Segar, Ahmed A Kolkailah, Robert Frederich, Annpey Pong, Christopher P Cannon, Francesco Cosentino, Samuel Dagogo-Jack, Darren K McGuire, Richard E Pratley, Chih-Chin Liu, Mario Maldonado, Jie Liu, Nilo B Cater, Ambarish Pandey, David Z I Cherney
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism 24 (9) (2022)
Matthew W Segar, Kershaw V Patel, Anne S Hellkamp, Muthiah Vaduganathan, Yuliya Lokhnygina, Jennifer B Green, Siu-Hin Wan, Ahmed A Kolkailah, Rury R Holman, Eric D Peterson, Vaishnavi Kannan, Duwayne L Willett, Darren K McGuire, Ambarish Pandey
Validation of the WATCH-DM and TRS-HF DM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis. Journal of the American Heart Association 11 (11) (2022)
Ann Marie Navar, Ahmed A Kolkailah, Robert Overton, Nishant P Shah, Justin F Rousseau, Greg C Flaker, Michael P Pignone, Eric D Peterson
Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020. Journal of the American Heart Association 11 (22) (2022)
Ahmed A Kolkailah, Ildiko Lingvay, Idit Dobrecky-Mery, Alona Aharonovich, Jens-Peter David, Cecilie Holse, Søren Rasmussen, Darren K McGuire
Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial. Diabetes, obesity & metabolism 25 (4) (2022)
Ahmed A Kolkailah, Ildiko Lingvay, Idit Dobrecky-Mery, Alona Aharonovich, Jens-Peter David, Cecilie Holse, Søren Rasmussen, Darren K McGuire
Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial. Diabetes, obesity & metabolism 25 (4) (2022)
Ahmed A Kolkailah, Stephen D Wiviott, Itamar Raz, Sabina A Murphy, Lawrence A Leiter, Deepak L Bhatt, Lawrence A Leiter, John P H Wilding, Ingrid Gause-Nilsson, Marc S Sabatine, Darren K McGuire
Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58. Diabetes care 45 (2) (2022)
David D Berg, Ahmed A Kolkailah, Ashish Sarraju, Anne Marie Kerchberger, Mahmoud Eljalby, Darren K McGuire
Interpreting Absolute and Relative Risk Reduction in the Context of Recent Cardiovascular Outcome Trials in Patients with Type 2 Diabetes. Current diabetes reports 21 (11) (2021)
Setri Fugar, Alexis K Okoh, Christopher Dodoo, Ahmed A Kolkailah, Edwin Okyne, Ebru Özturk, Alfred Solomon, Nana Ama Afari Yeboah, Tania Campagnoli, Annabelle Volgman, Kim Williams
Effect of intensive and standard blood pressure control on cardiovascular outcomes based on body mass index: sub-analysis of the sprint trial. Journal of human hypertension 34 (11) (2020)
Ahmed A Kolkailah, Rami Doukky, Marc P Pelletier, Annabelle S Volgman, Tsuyoshi Kaneko, Ashraf F Nabhan
Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Heart (British Cardiac Society) 106 (14) (2020)
Ahmed Al-Ogaili, Ali Ayoub, Luis Diaz Quintero, Christian Torres, Harry E Fuentes, Setri Fugar, Ahmed A Kolkailah, Wael Dakkak, Alfonso J Tafur, Neha Yadav
Rate and impact of venous thromboembolism in patients with ST-segment elevation myocardial infarction: Analysis of the Nationwide Inpatient Sample database 2003-2013. Vascular medicine (London, England) 24 (4) (2019)
Ahmed A Kolkailah, Rabah S Alreshq, Ahmed M Muhammed, Mohamed E Zahran, Marwah Anas El-Wegoud, Ashraf F Nabhan
Cochrane corner: is it better to access the coronary circulation via the radial or the femoral artery? Heart (British Cardiac Society) 105 (9) (2019)
Ahmed Al-Ogaili, Setri Fugar, Alexis K Okoh, Ahmed A Kolkailah, Nawaf Al Hashemi, Ali Ayoub, Mark J Russo, Clifford J Kavinsky
Trends in complete heart block after transcatheter aortic valve replacement: A population based analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 94 (6) (2019)
Ahmed A Kolkailah, Setri Fugar, Juan Rey-Mendoza, Tania Campagnoli, Sherene Fakhran
Revisiting the evolution of tuberculosis therapy: historical reflections in the modern era. Oxford medical case reports 2018 (9) (2018)